Therapeutic targeting of GSK‐3β activation by the tyrosine kinase RYK in pancreatic ductal adenocarcinoma with BJ‐2412, a novel sunitinib analogue

Documenti analoghi

• A Concise and High‐Yielding Synthesis of Dechlorotrichotoxin A
  di: Dawon Bae, et al.
  Pubblicazione: (2025)
• Discovery of a Novel Cyclobutanol Scaffold With Anti‐Inflammatory Activity and Its Modular Synthesis
  di: Chhabi Lal Chaudhary, et al.
  Pubblicazione: (2025)
• Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma
  di: Junki Fukuda, et al.
  Pubblicazione: (2024)
• Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
  di: Zheng Wu, et al.
  Pubblicazione: (2025)
• Molecular characteristics of early‐onset pancreatic ductal adenocarcinoma
  di: Silvana Debernardi, et al.
  Pubblicazione: (2024)